Zydus Lifesciences has launched two artificial intelligence-powered continuous glucose monitoring (CGM) devices — Diasens and GlucoLive — expanding its companion diagnostics portfolio as demand...
Zydus Lifesciences Ltdon Friday, February 27, said its in-licensed pembrolizumab biosimilar has met the primary endpoint in a pivotal pharmacokinetic (PK) study, paving the...
After nearly two years of correction in pharmaceutical stocks, valuations across the sector have turned more reasonable, prompting Elara Securities to turn constructive on...
Zydus Lifesciences shares will be in focus today (February 20) after the company said the United States Food and Drug Administration (USFDA) has completed...
Zydus Lifescience has announced the launch of a new drug. The Ahmedabad-based company said Anyra is India’s first indigenously developed biosimilar of Aflibercept 2...